Gamma Knife Radiosurgery
Gamma Knife Information
The Gold Standard for Non-Invasive Brain Radiosurgery
Since 1968, Gamma Knife radiosurgery has expanded treatment options for thousands of adult and pediatric patients with brain disorders worldwide. The Gamma Knife was first introduced in the United States in 1987 and JFK Medical Center began treating patients with their Gamma Knife in 2000.Gamma Knife radiosurgery is one of the most advanced technologies available for the non-invasive treatment of certain brain diseases. The Gamma Knife is considered the "gold standard" stereotactic radiosurgical treatment tool for brain tumors, AVMs and trigeminal neuralgia. The treatment uses a single high dose of precisely focused radiation through the intact skull to destroy, arrest or reduce tumors, close arteriovenous malformations, and alter the conducting pain fibers in cases of trigeminal neuralgia (facial pain) — all without harming or damaging surrounding healthy brain tissue. This means that many brain abnormalities once treated only through open brain surgery or whole brain irradiation can now be treated without an incision and in a single day. As a non-invasive treatment for individuals with select patient profiles, Gamma Knife radiosurgery offers a lower-risk, proven and cost-effective alternative or adjunct therapy to patients with brain tumors, AVMs and trigeminal neuralgia.
Treatment with the Gamma Knife has quickly become the best alternative and/or the primary treatment of choice for select patients because:
Contact Us:
The New Jersey Neuroscience Institute at JFK Medical Center
65 James Street
Edison, NJ
(732) 321-7010
- Advantages
- How We Can Help
- Treatment and Results
- Gamma Knife Vs. Cyberknife
- Frequently Asked Questions
- Treatment and Follow-Up
The Gold Standard for Non-Invasive Brain Radiosurgery
Since 1968, Gamma Knife radiosurgery has expanded treatment options for thousands of adult and pediatric patients with brain disorders worldwide. The Gamma Knife was first introduced in the United States in 1987 and JFK Medical Center began treating patients with their Gamma Knife in 2000.Gamma Knife radiosurgery is one of the most advanced technologies available for the non-invasive treatment of certain brain diseases. The Gamma Knife is considered the "gold standard" stereotactic radiosurgical treatment tool for brain tumors, AVMs and trigeminal neuralgia. The treatment uses a single high dose of precisely focused radiation through the intact skull to destroy, arrest or reduce tumors, close arteriovenous malformations, and alter the conducting pain fibers in cases of trigeminal neuralgia (facial pain) — all without harming or damaging surrounding healthy brain tissue. This means that many brain abnormalities once treated only through open brain surgery or whole brain irradiation can now be treated without an incision and in a single day. As a non-invasive treatment for individuals with select patient profiles, Gamma Knife radiosurgery offers a lower-risk, proven and cost-effective alternative or adjunct therapy to patients with brain tumors, AVMs and trigeminal neuralgia.
Treatment with the Gamma Knife has quickly become the best alternative and/or the primary treatment of choice for select patients because:
- The treatment is non-invasive.
- Typically patients can resume their pre-surgical routine within two to three days.
- No rehabilitation of the patient is usually required.
- It is designed specifically for the precise treatment of the brain only.
- Achieve sub-millimeter accuracy level of better than 0.3mm by using a stabilizing head frame.
- Uses state-of-the-art treatment planning software that combines data from three-dimensional computer imaging studies to precisely focus radiation.
- Able to treat multiple tumors inside the brain during a single treatment.
- The only stereotactic radiosurgical device that is FDA approved for the specific treatment of brain metastases, including multiple metastases.
Contact Us:
The New Jersey Neuroscience Institute at JFK Medical Center
65 James Street
Edison, NJ
(732) 321-7010